CRAT Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2713183

Dieses Recombinant CRAT-Protein wird in HEK-293 Cells exprimiert.

Kurzübersicht für CRAT Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag) (ABIN2713183)

Target: CRAT (Carnitine O-Acetyltransferase (CRAT))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Applikation: Antibody Production (AbP), Standard (STD)

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Produktdetails

Proteineigenschaft: Transcript Variant 2

Aufreinigungstag / Konjugat: Dieses CRAT Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Produktmerkmale:

• Recombinant human Carnitine acetyltransferase (CRAT), transcript variant 2 (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: CRAT (Carnitine O-Acetyltransferase (CRAT))

Andere Bezeichnung: Carnitine Acetyltransferase (Crat)

Hintergrund: Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase seems to affect the flux through the pyruvate dehydrogenase complex. It may be involved as well in the transport of acetyl-CoA into mitochondria. [UniProtKB/Swiss-Prot Function]

Molekulargewicht: 68.4 kDa

NCBI Accession: NP_003994

Pathways: Monocarboxylic Acid Catabolic Process